Youngy Health Co., Ltd. (SHE:300247)
China · Delayed Price · Currency is CNY 3.790
+0.120 (3.27%)
Jul 1, 2026, 3:04 PM CST
Youngy Health Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
| 3,047 | 4,125 | 2,878 | 2,862 | 2,854 | 3,715 | |
Market Cap Growth | -4.53% | 43.30% | 0.56% | 0.28% | -23.16% | 72.39% |
Enterprise Value | 2,639 | 3,789 | 2,455 | 2,434 | 2,540 | 3,516 |
Last Close Price | 3.79 | 5.13 | 3.58 | 3.56 | 3.55 | 4.62 |
PE Ratio | 46.63 | 55.14 | 61.44 | 107.68 | 22.60 | 153.48 |
Forward PE | - | 36.44 | 36.44 | 36.44 | 36.44 | 36.44 |
PS Ratio | 3.31 | 4.42 | 4.18 | 5.41 | 6.16 | 7.06 |
PB Ratio | 2.38 | 3.31 | 2.52 | 2.67 | 2.78 | 4.31 |
P/TBV Ratio | 2.72 | 3.75 | 2.81 | 2.94 | 3.02 | 4.79 |
P/FCF Ratio | 45.31 | 38.97 | 68.21 | 35.55 | - | 807.41 |
P/OCF Ratio | 37.35 | 35.65 | 56.38 | 32.38 | - | 343.25 |
EV/Sales Ratio | 2.86 | 4.06 | 3.56 | 4.60 | 5.48 | 6.68 |
EV/EBITDA Ratio | 16.26 | 24.77 | 31.04 | 48.52 | 465.70 | 119.24 |
EV/EBIT Ratio | 19.57 | 27.65 | 39.08 | 73.89 | - | 286.13 |
EV/FCF Ratio | 39.24 | 35.79 | 58.17 | 30.22 | - | 764.23 |
Debt / Equity Ratio | 0.06 | 0.06 | 0.01 | 0.02 | 0.03 | 0.04 |
Debt / EBITDA Ratio | 0.49 | 0.48 | 0.06 | 0.28 | 1.76 | 0.92 |
Debt / FCF Ratio | 1.17 | 0.75 | 0.13 | 0.22 | - | 6.99 |
Net Debt / Equity Ratio | -0.41 | -0.56 | -0.59 | -0.56 | -0.48 | -0.29 |
Net Debt / EBITDA Ratio | -3.51 | -4.55 | -8.54 | -11.95 | -90.94 | -8.53 |
Net Debt / FCF Ratio | -7.87 | -6.57 | -16.01 | -7.44 | 10.62 | -54.67 |
Asset Turnover | 0.65 | 0.66 | 0.55 | 0.44 | 0.42 | 0.53 |
Inventory Turnover | 3.28 | 3.16 | 2.94 | 2.20 | 2.11 | 3.10 |
Quick Ratio | 4.92 | 5.20 | 5.23 | 5.33 | 4.53 | 2.66 |
Current Ratio | 8.02 | 6.50 | 6.55 | 6.58 | 6.13 | 3.92 |
Return on Equity (ROE) | 8.25% | 9.06% | 5.97% | 3.99% | 14.11% | 3.72% |
Return on Assets (ROA) | 5.94% | 6.08% | 3.11% | 1.71% | -0.72% | 0.78% |
Return on Invested Capital (ROIC) | 14.94% | 19.70% | 10.02% | 4.59% | -2.19% | 1.71% |
Return on Capital Employed (ROCE) | 9.80% | 10.20% | 5.40% | 3.00% | -1.20% | 1.40% |
Earnings Yield | 2.22% | 1.81% | 1.63% | 0.93% | 4.42% | 0.65% |
FCF Yield | 2.21% | 2.57% | 1.47% | 2.81% | -1.64% | 0.12% |
Buyback Yield / Dilution | -6.40% | -6.43% | 11.87% | -12.24% | 2.15% | 1.81% |
Total Shareholder Return | -6.40% | -6.43% | 11.87% | -12.24% | 2.15% | 1.81% |